Viberzi and Nexium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viberzi (eluxadoline) and Nexium (esomeprazole magnesium). Common drug interactions include chronic kidney disease among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Viberzi and Nexium. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Viberzi?

Viberzi has active ingredients of eluxadoline. eHealthMe is studying from 3,077 Viberzi users. Check the latest studies of Viberzi.

What is Nexium?

Nexium has active ingredients of esomeprazole magnesium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 245,677 Nexium users. Check the latest studies of Nexium.



On Jul, 29, 2026

69 people who take Viberzi and Nexium together, and have interactions are studied.

Viberzi and Nexium drug interactions.

What are the common drug interactions of Viberzi and Nexium, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  7. Nausea (feeling of having an urge to vomit)
  8. Abdominal pain upper
  9. Abdominal pain
  10. Headache (pain in head)

male:

  1. Drug ineffective
  2. Abdominal pain
  3. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  4. Insomnia (sleeplessness)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain
  7. Constipation
  8. Enzyme level increased
  9. Sphincter of oddi dysfunction (dysfunction of a muscular valve that controls the flow of digestive juices)
  10. Anaemia (lack of blood)

What are the common drug interactions of Viberzi and Nexium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Vomiting

30-39:

  1. Enzyme level increased
  2. Sphincter of oddi dysfunction (dysfunction of a muscular valve that controls the flow of digestive juices)
  3. Abdominal pain
  4. Drug ineffective
  5. Pruritus (severe itching of the skin)
  6. Swelling
  7. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

  1. Sinusitis (inflammation of sinus)
  2. Stoma site reaction (reaction at abdominal opening)
  3. Surgical failure
  4. Upper respiratory tract infection
  5. Adenoma benign (non-cancerous tumour -secreting)
  6. Arthralgia (joint pain)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Colitis ulcerative (inflammation of colon with ulcer)
  9. Cough
  10. Dizziness

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Abdominal pain upper
  3. Anxiety
  4. Asthenia (weakness)
  5. Constipation
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Dizziness
  8. Dry mouth
  9. Epigastric discomfort
  10. Eye swelling

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Abdominal pain
  3. Pancreatitis (inflammation of pancreas)
  4. Abdominal pain upper
  5. Abdominal distension
  6. Anxiety
  7. Change of bowel habit
  8. Chest pain
  9. Diarrhoea
  10. Drug ineffective

What are the existing conditions these people have? *

  1. Irritable Bowel Syndrome: 33 people, 47.83%
  2. Depression: 13 people, 18.84%
  3. High Blood Pressure: 9 people, 13.04%
  4. Diarrhea: 9 people, 13.04%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 11.59%
  6. Stress And Anxiety: 7 people, 10.14%
  7. Pain: 7 people, 10.14%
  8. Immunodeficiency Common Variable: 7 people, 10.14%
  9. High Blood Cholesterol: 6 people, 8.70%
  10. Sleep Disorder: 5 people, 7.25%

* Approximation only. Some reports may have incomplete information.

Do you take Viberzi and Nexium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Viberzi and Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Viberzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nexium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viberzi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on eluxadoline and esomeprazole magnesium (the active ingredients of Viberzi and Nexium, respectively), and Viberzi and Nexium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: